EUVIMEDEUVIMED entdecken
Crossref

Sphingolipid metabolism controls mammalian heart regeneration

Xiaoqian Ji, Zihao Chen, Qiyuan Wang, Bin Li, Yan Wei, Yun Li, Jianqing Lin, Weisheng Cheng, Yijie Guo, Shilin Wu, Longkun Mao, Yuzhou Xiang und 8 weitere

Cell Metabolism · 2024-04 · 36 (4) · 839-856.e8

DOI: 10.1016/j.cmet.2024.01.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Metabolism, 2024-04. Verfasst von Xiaoqian Ji und 19 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangdong 510080, China; …. Hauptthemen laut MEDLINE: Sphingolipids, Heart, Lysophospholipids. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Taishan Scholar Foundation of Shandong Province, Guangdong Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Utilization of lipids as energy substrates after birth causes cardiomyocyte (CM) cell-cycle arrest and loss of regenerative capacity in mammalian hearts. Beyond energy provision, proper management of lipid composition is crucial for cellular and organismal health, but its role in heart regeneration remains unclear. Here, we demonstrate widespread sphingolipid metabolism remodeling in neonatal hearts after injury and find that SphK1 and SphK2, isoenzymes producing the same sphingolipid metabolite sphingosine-1-phosphate (S1P), differently regulate cardiac regeneration. SphK2 is downregulated during heart development and determines CM proliferation via nuclear S1P-dependent modulation of histone acetylation. Reactivation of SphK2 induces adult CM cell-cycle re-entry and cytokinesis, thereby enhancing regeneration. Conversely, SphK1 is upregulated during development and promotes fibrosis through an S1P autocrine mechanism in cardiac fibroblasts. By fine-tuning the activity of each SphK isoform, we develop a therapy that simultaneously promotes myocardial repair and restricts fibrotic scarring to regenerate the infarcted adult hearts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SphingolipidsHeartLysophospholipidsAnimalsSphingosineIsoenzymesMammalsPhosphotransferases (Alcohol Group Acceptor)

Stichwörter der Autor:innen

SphK1SphK2cardiac fibrosiscardiomyocyte proliferationheart regenerationsphingolipid metabolism

Substanzen

Sphingolipidssphingosine 1-phosphateSphingosineIsoenzymesPhosphotransferases (Alcohol Group Acceptor)Lysophospholipids

Autor:innen und Institutionen

  • Advanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangdong 510080, China; Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Labo…
  • Advanced Medical Technology Center, Zhongshan School of Medicine and the First Affiliated Hospital, Sun Yat-Sen University, Guangdong 510080, China; Key Laboratory for Stem Cells and Tissue Engineering (Sun Yat-Sen Univ…
  • China National Center for Bioinformation, Beijing 100101, China; CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; University of Ch…
  • School of Pharmacy, Guangdong Pharmaceutical University, Guangdong 510006, China.
  • Institute of Neurological and Psychiatric Disorders, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Shandong 266071, China.

Förderung

  • Taishan Scholar Foundation of Shandong Province
  • Guangdong Provincial Natural Science Foundation
  • National Natural Science Foundation of China
  • Qingdao Municipal Science and Technology Bureau
  • National Key Research and Development Program of China

Zitieren

APA

Ji, X., Chen, Z., Wang, Q., Li, B., Wei, Y., Li, Y., Lin, J., Cheng, W., Guo, Y., Wu, S., Mao, L., Xiang, Y., Lan, T., Gu, S., Wei, M., Zhang, J. Z., Jiang, L., Wang, J., Xu, J., & Cao, N. (2024). Sphingolipid metabolism controls mammalian heart regeneration. Cell Metabolism, 36(4), 839-856.e8. https://doi.org/10.1016/j.cmet.2024.01.017

Vancouver

Ji X, Chen Z, Wang Q, Li B, Wei Y, Li Y, et al. Sphingolipid metabolism controls mammalian heart regeneration. Cell Metabolism. 2024;36(4):839-856.e8. doi:10.1016/j.cmet.2024.01.017

BibTeX
@article{Ji2024,
  author = {Ji, Xiaoqian and Chen, Zihao and Wang, Qiyuan and Li, Bin and Wei, Yan and Li, Yun and Lin, Jianqing and Cheng, Weisheng and Guo, Yijie and Wu, Shilin and Mao, Longkun and Xiang, Yuzhou and Lan, Tian and Gu, Shanshan and Wei, Meng and Zhang, Joe Z and Jiang, Lan and Wang, Jia and Xu, Jin and Cao, Nan},
  title = {Sphingolipid metabolism controls mammalian heart regeneration},
  journal = {Cell Metabolism},
  year = {2024},
  volume = {36},
  number = {4},
  pages = {839--856.e8},
  doi = {10.1016/j.cmet.2024.01.017}
}
Kostenlos starten →